Newsroom
Latest news and features
OPPORTUNITIES TO PARTNER WITH BARDA
Follow Us
Be the first to know about BARDA news and new awards. Sign-up for our email announcements:
LATEST NEWS
BARDA and the Janssen Pharmaceutical Companies of Johnson & Johnson expand Phase 2a COVID-19 vaccine trial to include adolescent population
02 April 2021
LATEST NEWS
BARDA and Department of the Air Force’s Acquisition COVID-19 Task Force (DAF ACT) Awards $53.7 Million Contract to Ortho Clinical Diagnostics
01 April 2021
LATEST NEWS
News Release from PHE.gov: HHS launches $500,000 contest for design of new, effective, comfortable, masks designed for general public use
31 March 2021
NEWS
BARDA and FirstString Research announce partnership to repurpose aCT1 eye drops as a medical countermeasure against mustard gas keratopathy
30 March 2021
NEWS
BARDA expands partnership with DiaSorin SpA to develop automated antigen detection assay for acute COVID-19
29 March 2021
NEWS
BARDA partners with NCATS to seek submissions for the development of advanced microphysiological immune tissue platforms through its new DRIVe ImmuneChip+ program
15 March 2021
NEWS
BARDA and ContraFect partner to develop an antibacterial to treat Staphylococcus aureus bacteremia
12 March 2021
NEWS
BARDA and MediciNova, Inc. partner to repurpose MN-166 (ibudilast) as a medical countermeasure against chlorine exposure
09 March 2021
NEWS
BARDA expands partnership with Hologic for development of a fourth high-throughput molecular assay for SARS-CoV-2
02 March 2021
NEWS
NEWS RELEASE FROM PHE.GOV: Biden Administration secures supply of new COVID-19 therapeutic treatment
02 March 2021
NEWS
BARDA partners with LightDeck Diagnostics to develop a rapid, in vitro, point-of-care SARS-CoV-2 antigen test to detect SARS-CoV-2 infection
01 March 2021
NEWS
News Release from NIH.gov: Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Janssen COVID-19 Vaccine
27 February 2021
NEWS
BARDA and Luminex Corporation collaborate on a single, rapid diagnostic test to distinguish coronavirus from influenza and RSV infections
19 February 2021
NEWS
NEWS RELEASE FROM HHS.GOV: Biden Administration purchases additional doses of COVID-19 vaccines from Pfizer and Moderna
11 February 2021
NEWS
BARDA and Visby Medical partner to develop a rapid, hand-held, point-of-care and over-the-counter in vitro diagnostic test for influenza A/B and SARS-CoV-2.
02 February 2021
NEWS
BARDA, DOD, increase number of Lilly’s COVID-19 therapeutic treatment courses that can be purchased under agreement
13 January 2021
NEWS
BARDA and DiaSorin Molecular LLC collaborate on SARS-CoV-2 diagnostic test to distinguish coronavirus from influenza infections
13 January 2021
NEWS
NEWS RELEASE FROM PHE.GOV: HHS, DOD purchase additional doses of Regeneron’s antibody therapeutic to treat patients with mild to moderate COVID-19
12 January 2021
NEWS
BARDA DRIVe and NIOSH seek expert input on criteria for upcoming mask innovation challenge
07 January 2021
NEWS
News release from HHS.Gov: HHS, DOD collaborate with Merck to continue the development and large-scale manufacturing of investigational COVID-19 treatment
23 December 2020
NEWS
News Release from HHS.gov: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Pfizer
23 December 2020
NEWS
BARDA announces the 57th FDA Approval/Licensure/Clearance for Medical Countermeasures supported by BARDA under Novel Public Private Partnerships
21 December 2020
NEWS
News Release from NIH.gov: Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine
18 December 2020
NEWS
NEWS RELEASE FROM HHS.GOV: HHS, DOD engage Quantum Leap Healthcare Collaborative in search for effective treatments for the sickest COVID-19 patients
15 December 2020
NEWS
News Release from HHS.GOV: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Moderna
11 December 2020
NEWS
BARDA and Chembio Diagnostics collaborate on two rapid point-of-care diagnostic tests to both detect antigens for COVID-19 and detect and differentiate Influenza from COVID-19.
03 December 2020
NEWS
BARDA DRIVe seeking interested applicants for the Early Notification to Act, Control, and Treat (ENACT) program
02 December 2020
NEWS
News release from HHS.gov: Trump Administration purchases additional doses of Lilly therapeutic to treat patients with mild to moderate COVID-19
02 December 2020
NEWS
BARDA is partnering with Chrysalis BioTherapeutics to continue development of TP508 as a nuclear countermeasure
30 November 2020
NEWS
BARDA partners with Siemens Healthineers to expedite development of a high-throughput, automated antigen test for COVID-19
24 November 2020
NEWS
News release from HHS.gov: HHS Provides $25 Million to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests
23 November 2020
NEWS
BARDA expands partnership with DiaSorin Inc to develop an enhanced IgG assay for determining COVID-19 patient exposure and immune status
16 November 2020
NEWS
BARDA seeks nonprofit partner for BARDA Ventures: Catalyzing the 21st Century Cures Act and launching a new way to do business with HHS
10 November 2020
NEWS
BARDA and JPEO-CBRND help Humanigen evaluate drug to potentially prevent or treat cytokine storm caused by COVID-19
06 November 2020
NEWS
BARDA and Mesa Biotech collaborate on rapid diagnostics to distinguish coronavirus from influenza infections
06 November 2020
NEWS
News release from HHS.gov: HHS and DOD announce $12.7 million contract with InBios International to boost U.S. production of rapid COVID-19 tests
02 November 2020
NEWS
News release from HHS.gov: HHS and DOD Announce $119 Million Contract to Hologic to Better Meet the Demand of COVID-19 Testing
02 November 2020
NEWS
HHS, BARDA partner with Hologic to expedite development of a high-throughput, automated multiplex SARS-CoV-2/Flu assay
29 October 2020
NEWS
BARDA seeks abstract submissions for medical countermeasure development through the DRIVe ReDIRECT Program
28 October 2020
NEWS
HHS, DOD Collaborate on Plans to Purchase Lilly Investigational Therapeutic to Treat COVID-19
28 October 2020
NEWS
BARDA and Beckman Coulter partner to aid in rapid detection of MIS-C, a pediatric complication of SARS-CoV-2 infection
15 October 2020
NEWS
News Release from HHS.gov: Trump Administration expands manufacturing capacity with Cytiva for components of COVID-19 vaccines
13 October 2020
LATEST PUBLICATIONS
National Action Plan for Combating Antibiotic-Resistant Bacteria 2020-2025
09 October 2020
NEWS
Trump Administration expands collaboration with AstraZeneca to develop and manufacture an investigational monoclonal antibody to prevent COVID-19
09 October 2020
NEWS
BARDA and Current Health partner on remote monitoring to predict likelihood of hospitalization and need for ICU-level support in COVID-19 patients
07 October 2020
NEWS
BARDA and DOD JPEO-CBRND Collaborate with Cepheid on Single, Rapid Diagnostic Test to Detect COVID-19, Influenza and RSV
07 October 2020
NEWS
BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin
05 October 2020
NEWS
Two novel investigational drugs targeting antibiotic-resistant infections move into advanced development with HHS support
30 September 2020
NEWS
BARDA partners with Invirsa to develop a treatment for ocular conditions associated with DNA damage, including sulfur mustard injury
29 September 2020
NEWS
BARDA awards additional funds to Basilea for next steps in antibiotic development to treat bloodstream infections caused by Staphylococcus aureus bacteria
28 September 2020
NEWS
BARDA and Luminex Corporation partner to expedite development of COVID-19 diagnostic test
24 September 2020
NEWS
BARDA and Luminex Corporation enter into a public-private partnership to develop an advanced serology test for use during the COVID-19 pandemic
23 September 2020
NEWS
BARDA Partners with University of Pennsylvania Researchers to Develop a Lung-on-a-Chip for Discovery of Treatments for Chlorine Exposure
21 September 2020
NEWS
BARDA expanded partnership with Ortho Clinical Diagnostics to develop high-throughput, automated COVID-19 antigen and further advancements to antibody tests
18 September 2020
NEWS
BARDA and JPEO-CBRND partner with Ology Bioservices to expand domestic fill-finish capacity for COVID-19 countermeasures under Operation Warp Speed
17 September 2020
NEWS
BARDA collaborates with NOWDiagnostics, Inc. to develop a rapid, point-of-care (POC) and over-the-counter (OTC), in vitro diagnostic test to detect antibodies against SARS-CoV-2
31 August 2020
NEWS
BARDA establishes four new partnerships to explore innovative vaccine delivery technologies
26 August 2020
NEWS
Trump Administration collaborates with Moderna to produce 100 million doses of COVID-19 investigational vaccine
11 August 2020
NEWS
BARDA and JPEO-CBRND partner with Grand River Aseptic Manufacturing to expand domestic fill-finish capacity for COVID-19 countermeasures under Operation Warp Speed
06 August 2020
NEWS
HHS, DOD collaborate with Johnson & Johnson to produce millions of COVID-19 investigational vaccine doses
05 August 2020
NEWS
HHS, DOD partner with Sanofi and GSK on commercial-scale manufacturing demonstration project to produce millions of COVID-19 investigational vaccine doses
31 July 2020
NEWS
BARDA continues to partner with Moderna for the first Phase 3 clinical trial of a COVID-19 vaccine to start in the United States
28 July 2020
NEWS
HHS reserves and rapidly expands manufacturing capacity for COVID-19 vaccines at Texas Center for Innovation in Advanced Development and Manufacturing
27 July 2020
NEWS
BARDA and JPEO-CBRND form partnership with Smiths Medical to expand domestic manufacturing capacity for safety needles and syringes
15 July 2020
NEWS
BARDA and JPEO-CBRND work with Retractable Technologies, Inc. to expand manufacturing of needles and syringes in the US
09 July 2020
NEWS
BARDA and JPEO-CBRND establish partnership with Becton Dickinson to expand domestic manufacturing capacity for needles and syringes
09 July 2020
NEWS
BARDA and DoD work with SiO2 Materials Science to increase domestic manufacturing of vials
07 July 2020
NEWS
HHS, DOD collaborate with Novavax to produce millions of COVID-19 investigational vaccine doses in commercial-scale manufacturing demonstration project
07 July 2020
NEWS
HHS, DOD collaborate with Regeneron on large-scale manufacturing demonstration project of COVID-19 investigational therapeutic treatmen
07 July 2020
NEWS
BARDA partners with Chembio Diagnostics, Inc. to develop a point-of-care in vitro diagnostic test for the detection of SARS-CoV-2 in respiratory specimens
06 July 2020
NEWS
BARDA and Sonica Health expand partnership to develop wearable patch as an early monitoring platform for COVID-19 infection
01 July 2020
NEWS
BARDA partners with Colorado State University’s Infectious Disease Research Center (IDRC) to further develop the SolaVAXTM platform to address COVID-19
25 June 2020
NEWS
BARDA Teams Up with DoD’s JPEO-CBRN and Corning Incorporated to Expand Production of Corning’s Valor ® Glass Vials
19 June 2020
NEWS
BARDA & Empatica forge new partnership to develop an early monitoring platform to identify COVID-19 infection
19 June 2020
NEWS
BARDA supports development of two automated antibody tests for COVID-19 by Ortho Clinical Diagnostics
17 June 2020
NEWS
BARDA and Immunexpress Inc. expand partnership to evaluate a sepsis host-based laboratory diagnostic to triage COVID-19 patients
16 June 2020
NEWS
BARDA DRIVe and Sepsis Alliance to provide educational content on COVID-19 and Sepsis
11 June 2020
NEWS
BARDA, Snapdragon Chemistry Inc., demonstrate deployable domestic manufacturing technology for COVID-19 vaccine component
11 June 2020
NEWS
BARDA, Chembio Diagnostics Partnership Results in FDA-Cleared Diagnostic Test for Zika
10 June 2020
NEWS
BARDA engages Moderna to expand domestic manufacturing of the Moderna SARS-CoV-2 vaccine (mRNA-1273) to protect against COVID-19
05 June 2020
NEWS
BARDA announces partnership with Siemens Healthineers to develop automated total antibody test for COVID-19
02 June 2020
NEWS
BARDA and Genentech expand partnership to begin Phase 2 clinical trial to evaluate investigational treatments for COVID-19 patients
01 June 2020
NEWS
HHS Adds $628 Million to Contract with Emergent BioSolutions to Secure Manufacturing Capacity for Operation Warp Speed
01 June 2020
NEWS
BARDA partners with Merck and IAVI to accelerate development of a vaccine to prevent COVID-19
26 May 2020
NEWS
Trump Administration’s Operation Warp Speed accelerates AstraZeneca COVID-19 vaccine to be available beginning in October
21 May 2020
NEWS
BARDA and VitalConnect partner to monitor nursing home and COVID-19 patients for early indication of patient deterioration
20 May 2020
NEWS
HHS, industry partners expand U.S.-based pharmaceutical manufacturing for COVID-19 response
19 May 2020
NEWS
BARDA announces expanded partnership with Beckman Coulter to assess digital sepsis prediction solution for COVID-19 patients
15 May 2020
NEWS
BARDA supports development of AI-based handheld ultrasound to triage trauma or lung injuries and disease diagnosis, including COVID-19
08 May 2020
NEWS
BARDA engages in a collaboration to support Mayo Clinic Expanded Access Program for use of convalescent plasma to hospitalized patients with COVID-19
04 May 2020
NEWS
BARDA expands partnership with Hologic for development of a second high-throughput molecular assay for SARS-CoV-2
01 May 2020
NEWS
BARDA expands collaboration with Cerus Corporation to evaluate the INTERCEPT Blood System against SARS-CoV-2
28 April 2020
NEWS
BARDA and InBios International, Inc. partner to expedite development for serological tests to identify asymptomatic or recovered cases of COVID-19
27 April 2020
NEWS
BARDA and America’s Blood Centers partner to support and coordinate collection and distribution of convalescent plasma units for COVID-19 patients’ therapeutic use
27 April 2020
NEWS
BARDA announces partnership expansion with Cytovale, Inc. for continued development of Cytovale’s rapid diagnostic system for sepsis as part of COVID-19 pandemic response
23 April 2020
LATEST PUBLICATIONS
Assistant Secretary for Preparedness and Response (ASPR) Strategic Plan for 2020-2023
20 April 2020
NEWS
BARDA and Tangen Biosciences, Inc. entered into a public-private partnership to develop a rapid diagnostic test for SARS-CoV-2
20 April 2020
NEWS
BARDA supports Hememics Biotechnologies, Inc to develop a rapid antigen and antibody diagnostic to identify current or past SARS-CoV-2 infections in 60 seconds
16 April 2020
NEWS
BARDA and American Red Cross collaborate on convalescent plasma for therapeutic use in COVID-19 infected patients
15 April 2020
NEWS
BARDA and Vela Diagnostics USA, Inc. entered into a public-private partnership to develop a rapid diagnostic test for the COVID-19 pandemic
14 April 2020
NEWS
HHS/BARDA supports DiaSorin, Inc to develop a fully automated serology test to detect novel coronavirus infections
13 April 2020
NEWS
HHS supports Nanomix, Inc to develop a rapid mobile diagnostic test to detect presence of current or past COVID-19 infection in patients
08 April 2020
NEWS
HHS, Department of Defense, and Grifols Collaborate to Develop Plasma-based Treatment for COVID-19
07 April 2020
NEWS
BARDA leverages CIADM Partner for Development of Plasma-based Therapeutic Treatment for COVID-19
07 April 2020
NEWS
BARDA and Genentech collaborate to accelerate clinical trial of a novel COVID-19 therapeutic treatment
07 April 2020
NEWS
HHS accepts donations of medicine to Strategic National Stockpile as possible treatments for COVID-19 patients
06 April 2020
NEWS
BARDA is partnering with OraSure Technologies Inc. to develop first rapid at-home COVID-19 diagnostic test
06 April 2020
NEWS
BARDA, Department of Defense, and SAb Biotherapeutics to Partner to Develop a Novel COVID-19 Therapeutic
01 April 2020
NEWS
BARDA Supports Luminex Corporation Development of a Second Diagnostic Test to Detect Novel Coronavirus Infections
01 April 2020
NEWS
HHS engages Moderna’s mRNA technology to accelerate development of a COVID-19 vaccine
31 March 2020
NEWS
Janssen Research and Development partner with BARDA to accelerate clinical trials and manufacturing of COVID-19 vaccine
31 March 2020
NEWS
Cue Health partners with BARDA for the development of a rapid, point-of-care SARS-CoV-2 Test
31 March 2020
NEWS
BARDA and Luminex Corporation Partner to Expedite Development and EUA Clearance for COVID-19 Diagnostic Test
31 March 2020
NEWS
HHS, DoD collaborate with Cepheid on rapid diagnostics to detect coronavirus infections
22 March 2020
NEWS
HHS, DoD collaborate with Mesa Biotech on rapid diagnostics to detect coronavirus infections
20 March 2020
NEWS
HHS Supports Development of First High-Throughput COVID-19 Diagnostic Test; SARS-CoV-2; EZ-BAA
09 March 2020
NEWS
HHS Engages Sanofi’s Recombinant Technology for 2019 Novel Coronavirus Vaccine
18 February 2020
NEWS
New Pandemic Influenza Vaccine Uses Next Generation Technology to Strengthen Health Security
03 February 2020
NEWS
Secretary Azar Declares Public Health Emergency for United States for 2019 Novel Coronavirus
31 January 2020
NEWS
HHS Invests in Modernizing U.S. Manufacturing Capacity for Pandemic Influenza Vaccine; Sanofi Pasteur
09 December 2019
NEWS
HHS Advances Development of Tests to Distinguish Bacterial from Viral Infections across Multiple Healthcare Settings
14 November 2019
NEWS
FDA allows marketing of first rapid diagnostic test for detecting Ebola virus antigens
10 October 2019
NEWS
HHS Explores Lung-on-a-Chip Technology in Developing Chemical Injury Treatments
08 October 2019
NEWS
HHS advances novel technology to meet need for blood platelets in a nuclear disaster
30 September 2019
NEWS
Newly FDA-Licensed Vaccine for the Prevention of Smallpox & Monkeypox Marks Major Milestone in Domestic & Global Health Security
24 September 2019
NEWS
HHS Provides Expertise, $14 Million to Advance Development of Investigational Ebola Treatment
20 September 2019
NEWS
HHS, DoD, VenatoRx Pharmaceuticals to co-develop novel antibiotic to treat drug-resistant infections
22 July 2019
NEWS
First medical product cleared in U.S. for use on certain injuries caused by sulfur mustard
22 July 2019
NEWS
New HHS-Sponsored Research Provides New Tool and Updated Guidance on Mass Chemical Decontamination
21 February 2019
NEWS
HHS, Genentech join forces on medicines to combat influenza, other health security threats
01 October 2018
NEWS
HHS, DoD, Spero co-sponsor novel oral antibiotic development to treat deadly infections
16 July 2018
NEWS
Philadelphia company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
NEWS
Houston company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
NEWS
New York Tristate Area company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
NEWS
New Orleans company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
NEWS
Los Angeles company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
NEWS
Greater Boston company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
NEWS
Raleigh-Durham company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
NEWS
Seattle-Bellevue company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
NEWS
New BARDA Funding Opportunity Announcement: BARDA Division of Research, Innovation and Ventures (DRIVe) Accelerator Network
18 April 2018
NEWS
Decontamination Decoded: Disrobing, Dry Wiping Removes 99% of Chemical Contaminants
11 April 2018
MEETINGS
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholders Workshop 2016
06 January 2016
MEETINGS
2007 Biomedical Advanced Research and Development Authority (BARDA) Industry Day
03 August 2007
Portfolio
BARDA COVID-19 Medicalcountermeasure Portfolio
COVID-19 Portfolio
BARDA COVID-19 Medical Countermeasure Support Service Partners
COVID-19 Portfolio
BARDA COVID-19 Domestic Manufacturing & Infrastructure Investments
COVID-19 Portfolio
Sepsis Portfolio
Program Portfolio
ChemicalL, Biological, Radiological, and Nuclear (CBRN) Portfolio
Program Portfolio